Cas:10191-41-0 Vitamin E manufacturer & supplier

Chemical Name:Vitamin E

CAS.NO:10191-41-0

Synonyms:(2R)-2,5,7,8-tetramethyl-2-[(4S,8S)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-chromen-6-ol;DL-TOCOPHEROL;dl-alpha-Tocopherol(E);ecyl);ephanyl;alpha-Tocopherol;(±)-α-Tocopherol;(2R)-2,5,7,8-Tetramethyl-2-[(4S,8S)-4,8,12-trimethyltridecyl]chroman-6-ol;2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-[(4S,8S)-4,8,12-trimethyltridecyl]-, (2R)-;vitamin;A-TOCOPHEROL;Irganox E 201;(2R)-2,5,7,8-Tetramethyl-2-[(4S,8S)-4,8,12-trimethyltridecyl]-6-chromanol;MFCD00072051;DL-VITAMIN E;dl-Alpha-Tocopherol;EINECS 233-466-0;DL-α-Tocopherol;(+/-)-alpha-Tocopherol,synthetic

Molecular Formula:C₂₉H₅₀O₂

Molecular Weight:430.706

HS Code:

Physical and Chemical Properties:

Melting point:2-4°C

Boiling point:485.9±0.0 °C at 760 mmHg

Density:0.9±0.1 g/cm3

Index of Refraction:1.495

PSA:29.46000

Exact Mass:430.381073

LogP:11.90

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like (2R)-2,5,7,8-tetramethyl-2-[(4S,8S)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-chromen-6-ol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(+/-)-alpha-Tocopherol,synthetic physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,A-TOCOPHEROL Use and application,dl-Alpha-Tocopherol technical grade,usp/ep/jp grade.

Related News: In addition, a high-standard GMP workshop is under construction and is expected to be put into production within the year. As the capacity bottleneck is broken, the pharmaceutical intermediate business is expected to grow rapidly in the future, providing the company with new growth momentum. Vitamin E manufacturer The Breakthrough Designation for the iLet Bionic Pancreas System contemplates configurations with most insulin analogs approved for pumping as well as dasiglucagon, Zealand Pharma��s stable pumpable glucagon analog, which has a unique stability profile in a ready-to-use aqueous solution. Vitamin E supplier In addition, a high-standard GMP workshop is under construction and is expected to be put into production within the year. As the capacity bottleneck is broken, the pharmaceutical intermediate business is expected to grow rapidly in the future, providing the company with new growth momentum. Vitamin E vendor Pharmaceutical intermediates: chemical raw materials or chemical products used in the process of pharmaceutical synthesis, are intermediate products in the process of producing APIs, and can be further processed into APIs. Vitamin E factory Currently allowed as a second-line treatment, Sarclisa is expected to have top-line data from the phase 3 IMROZ trial later this year. The trial is adding Sarclisa to a VRd cocktail of Velcade, Revlimid and dexamethasone, which has established itself as the standard-of-care first-line therapy for patients with myeloma.